MENU
MXCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MaxCyte (MXCT) Earnings Date & Reports

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development... Show more

A.I. Advisor
published Earnings

MXCT is expected to report earnings to fall 14.16% to -10 cents per share on March 17

MaxCyte MXCT Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Est.
$-0.11
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.02
The last earnings report on November 12 showed earnings per share of -11 cents, missing the estimate of -11 cents. With 143.06K shares outstanding, the current market capitalization sits at 168.97M.
View a ticker or compare two or three
MXCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MXCT showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
9713 Key West Avenue
Phone
+1 301 944-1700
Employees
143
Web
https://www.maxcyte.com